Published in J Neurooncol on January 06, 2007
Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev (2009) 1.05
Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol (2009) 0.92
Primary extramedullary ependymoma of the cervical spine : case report and review of the literature. J Korean Neurosurg Soc (2011) 0.91
Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro Oncol (2012) 0.86
Prognosis by tumor location in adults with intracranial ependymomas. J Clin Neurosci (2014) 0.83
Treatment results in the differential surgery of intradural extramedullary schwannoma of 110 cases. PLoS One (2013) 0.81
Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys (2012) 0.80
Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro Oncol (2013) 0.80
Surgical considerations of spinal ependymomas in the pediatric population. Childs Nerv Syst (2009) 0.79
Histologic grade and extent of resection are associated with survival in pediatric spinal cord ependymomas. Childs Nerv Syst (2013) 0.77
Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci (2013) 0.75
Ependymomas of the filum terminale: The role of surgery and radiotherapy. Surg Neurol Int (2012) 0.75
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol (2007) 5.23
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res (2007) 3.05
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys (2003) 2.58
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol (2012) 2.24
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med (2003) 2.16
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer (2013) 2.10
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology (2013) 2.08
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys (2002) 1.85
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys (2005) 1.83
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys (2012) 1.70
Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg (2011) 1.64
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. Int J Radiat Oncol Biol Phys (2010) 1.64
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups. Int J Radiat Oncol Biol Phys (2006) 1.62
Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr (2008) 1.59
Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging (2005) 1.52
Tools for consensus analysis of experts' contours for radiotherapy structure definitions. Radiother Oncol (2010) 1.36
Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys (2012) 1.35
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology (2008) 1.32
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.32
Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.22
The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. Int J Radiat Oncol Biol Phys (2002) 1.18
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol (2008) 1.17
Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys (2011) 1.16
Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03. Int J Radiat Oncol Biol Phys (2008) 1.10
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. J Neurooncol (2011) 1.09
Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. J Oncol Pract (2013) 1.05
Childhood and adolescent thyroid carcinoma. Cancer (2002) 1.04
Postoperative radiation therapy for grade II and III intracranial ependymoma. Int J Radiat Oncol Biol Phys (2005) 1.03
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997. Med Pediatr Oncol (2002) 1.03
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02. Int J Radiat Oncol Biol Phys (2008) 1.03
Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06. Int J Radiat Oncol Biol Phys (2012) 1.00
Event (error and near-miss) reporting and learning system for process improvement in radiation oncology. Med Phys (2010) 0.98
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys (2013) 0.96
Survival following gamma knife radiosurgery for brain metastasis from breast cancer. Radiat Oncol (2013) 0.96
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer (2013) 0.94
Future vision for the quality assurance of oncology clinical trials. Front Oncol (2013) 0.93
Metachronous secondary atypical meningioma and anaplastic astrocytoma after postoperative craniospinal irradiation for medulloblastoma. Childs Nerv Syst (2006) 0.92
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States. Brachytherapy (2007) 0.90
Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys (2011) 0.89
Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib. J Clin Oncol (2012) 0.89
The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803. Int J Radiat Oncol Biol Phys (2013) 0.88
Imaging response in malignant glioma, RTOG 90-06. Am J Clin Oncol (2007) 0.88
Tilting of radioactive plaques after initial accurate placement for treatment of uveal melanoma. Arch Ophthalmol (2008) 0.87
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure. Urology (2006) 0.86
Alterations of protein 4.1 family members in ependymomas: a study of 84 cases. Mod Pathol (2005) 0.86
Postoperative imaging surveillance in pediatric pilocytic astrocytomas. J Neurosurg Pediatr (2010) 0.86
Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery (2014) 0.86
Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases. Surg Neurol (2008) 0.85
Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomy. Clin Prostate Cancer (2003) 0.85
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. Int J Radiat Oncol Biol Phys (2012) 0.84
Radiation medicine innovations for the new millenium. J Natl Med Assoc (2003) 0.83
Adaptive radiation therapy for postprostatectomy patients using real-time electromagnetic target motion tracking during external beam radiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.83
A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Radiat Oncol (2014) 0.83
Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery (2014) 0.83
Oligodendrogliomas in children. J Neurooncol (2011) 0.82
Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol (2013) 0.82
Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy. Am J Clin Oncol (2010) 0.79
Radiosurgical posterior corpus callosotomy in a child with Lennox-Gastaut syndrome. Case report. J Neurosurg (2007) 0.79
Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol (2003) 0.79
Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiother Oncol (2012) 0.79
Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Cancer (2013) 0.79
Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol. Brachytherapy (2006) 0.78
Inter-institutional variation of implant activity for permanent prostate brachytherapy. Brachytherapy (2008) 0.78
Extra-CNS metastasis from glioblastoma: a rare clinical entity. Expert Rev Anticancer Ther (2015) 0.77
Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT. World J Urol (2014) 0.77
Recurrent adult-onset hypophyseal Langerhans cell histiocytosis after radiotherapy: a case report. J Med Case Rep (2012) 0.77
Dose distribution outside of a sphere of P-32 chromic phosphorous colloid. Int J Radiat Oncol Biol Phys (2005) 0.76
The efficacy of stereotactic radiosurgery in the management of intracranial ependymoma. J Neurooncol (2004) 0.76
Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. Neurosurgery (2016) 0.76
Do not count out external-beam radiation therapy for high-risk prostate cancer. J Clin Oncol (2010) 0.75
Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy. Radiother Oncol (2012) 0.75
A comparative study based on image quality and clinical task performance for CT reconstruction algorithms in radiotherapy. J Appl Clin Med Phys (2016) 0.75
Gamma knife radiosurgery for trigeminal neuralgia: the Washington University initial experience. Stereotact Funct Neurosurg (2005) 0.75
The efficacy of radiation therapy in the management of grade I astrocytomas. J Neurooncol (2005) 0.75
New Developments in Radiation Oncology. Mo Med (2015) 0.75
Impact of orally disintegrating olanzapine on use of intramuscular antipsychotics, seclusion, and restraint in an acute inpatient psychiatric setting. J Clin Psychopharmacol (2006) 0.75
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. Oncology (Williston Park) (2016) 0.75
Gamma knife surgery for a hemangioma of the cavernous sinus in a child. J Neurosurg Pediatr (2012) 0.75
Dose escalation in locally advanced carcinoma of the prostate. Semin Radiat Oncol (2003) 0.75
What is the most appropriate clinical target volume for glioblastoma? CNS Oncol (2013) 0.75
Three-dimensional conformal therapy versus standard radiation therapy in localized carcinoma of prostate: an update. Clin Prostate Cancer (2002) 0.75
Uncertainties in radiation therapy: target volume definition in prostate cancer. Rays (2004) 0.75
Planning tools for modulated electron radiotherapy. Med Phys (2010) 0.75